GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 182 ( ` in lakhs) Note No. As at March 31, 2022 As at March 31, 2021 ASSETS Non-current assets Investment properties 2 2.08 2.08 Financial assets (i) Loans 3 - - (ii) Other financial assets 1.45 1.45 Current tax assets (net) 4,72.84 4,97.08 Deferred tax assets (net) 25 36.43 1,45.68 Other non-current assets 4 7,32.38 4,28.70 12,45.18 10,74.99 Current assets Inventories 5 21,98.22 23,35.96 Financial Assets (i) Cash and cash equivalents 6 5,39.59 28.72 (ii) Other financial assets 7 12,97.17 10,45.50 Other current assets 8 1,15.42 1,15.40 41,50.40 35,25.58 TOTAL ASSETS 53,95.58 46,00.57 EQUITY AND LIABILITIES Equity Equity share capital 9 & 17 96.00 96.00 Other Equity 10 8,87.51 4,68.16 Total equity 9,83.51 5,64.16 LIABILITIES Non-current liabilities Financial liabilities (i) Borrowings 11 14,60.00 - (ii) Other financial liabilities 12 1.35 1.35 Provisions 13 1,25.33 1,25.33 15,86.68 126.68 Current liabilities Financial liabilities (i) Trade payables 14 Total outstanding dues of micro enterprises and small enterprises 18.32 - Total outstanding dues of creditors other than micro enterprises and small enterprises 27,91.52 22,07.94 Other current liabilities 15 15.55 17,01.79 28,25.39 39,09.73 TOTAL EQUITY AND LIABILITIES 53,95.58 46,00.57 BIDDLE SAWYER LIMITED Balance Sheet as at March 31, 2022 BIDDLE SAWYER LIMITED Statement of profit and loss for the year ended March 31, 2022 As per our report of even date attached For and on behalf of the Board For CORNELIUS & DAVAR CHARTERED ACCOUNTANTS (Firm’s Registration No.101963W) S. Venkatesh Director DIN: 07263117 J. Chandy Director DIN: 09530618 RUSTOM D. DAVAR (PARTNER) Membership No. F10620 R. Mota Company Secretary ACS 38473 Place : Mumbai Date: May 9, 2022 UDIN: 22010620AIQVGD8202 Place : Mumbai Date: May 9, 2022 As per our report of even date attached For and on behalf of the Board For CORNELIUS & DAVAR CHARTERED ACCOUNTANTS (Firm’s Registration No.101963W) S. Venkatesh Director DIN: 07263117 J. Chandy Director DIN: 09530618 RUSTOM D. DAVAR (PARTNER) Membership No. F10620 R. Mota Company Secretary ACS 38473 Place : Mumbai Date: May 9, 2022 UDIN: 22010620AIQVGD8202 Place : Mumbai Date: May 9, 2022 Note No. For the year ended March 31, 2022 For the year ended March 31, 2021 Revenue from Operations 18 80,82.46 12,56.22 Other Income 19 0.79 39.49 Total income 80,83.25 12,95.71 Expenses Cost of materials consumed 20 58,70.57 19,38.60 Changes in inventories of work- in-progress, stock-in-trade and finished goods 21 1,74.71 (11,89.80) Finance costs 22 45.43 - Other expenses 23 14,32.06 4,70.69 Total expenses 75,22.77 12,19.49 Profit/(loss) before exceptional and items and tax 5,60.48 76.22 Exceptional items - - Profit/(loss) before tax 5,60.48 76.22 Income tax expenses Current tax 25 31.88 - Deferred tax 25 1,09.25 18.24 Profit / (loss) for the period 4,19.35 57.98 Other Comprehensive Income Items that will not be reclassified to profit or loss Remeasurements of defined benefit liability (asset) - - Income tax relating to items that will not be reclassified to profit or loss - - - - Total Comprehensive Income / (loss) for the period 4,19.35 57.98 Profit /(loss) attributable to: Owners of the Company 4,19.35 57.98 Total comprehensive income / (loss) attributable to: Owners of the Company 4,19.35 57.98 Earnings per equity share 24 43.68 6.04 Basic and diluted earnings per share The accompanying notes are an integral part of these financial statements ( ` in lakhs)